Alterations of c-myc Expression by Antisense Oligodeoxynucleotides Enhance the Induction of Apoptosis in HL-60 Cells

Cancer Research

Volumn 55, Issue 6, 1995, Pages 1379-1384

  Kimura, Shinya ^a   Hirakawa, Kouichi ^a   Maekawa, Taira ^a   Abe, Tatsuo ^a   Murakami, Akira ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL;

APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL DIVISION; HUMAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-MYC; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028935119     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bishop, J. M. Molecular themes in oncogenesis. Cell, 64:235–248, 1991.
2. Thompson, C. B., Challoner, P. B., Neiman, P. E., and Groudine, M. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (Lond.), 314:363–366, 1985.
3. Collins, S., and Groudine, M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukemia cell line. Nature (Lond.), 298:679–681, 1982.
4. Wyllie, A. H., Rose, K. A., Morris, R. G., Steel, C. M., Foster, E., and Spandidos, D. A. Rodent fibroblast tumours expressing human myc and ras genes:growth, metastasis and endogenous oncogene expression. Br. J. Cancer, 56:251–259, 1987.
5. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69:119–128, 1992.
6. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Washington DC), 257:212–214, 1992.
7. Alnemri, E. S., Fernandes, T. F., Haldar, S., Croce, C. M., and Litwack, G. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B- leukemias. Cancer Res., 52:491–495, 1992.
8. Oritani, K., Kaisho, T., Nakajima, K., and Hirano, T. Retinoic acid inhibits interleu-kin-6-induced macrophage differentiation and apoptosis in a murine hematopoietic cell line, Y6. Blood, 80:2298- 2305, 1992.
9. Wickstrom, E. L., Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H., and Wickstrom, E. Human promyelocyte leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA, 85:1028–1032, 1988.
10. Holt, J. T., Redner, R. L., and Nienhuis, A. W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell. Biol., 8:963–973, 1988.
11. Maekawa, T., Sonoda, Y., Kuzuyama, Y., Inazawa, J., Kimura, S., Nakamichi, K., and Abe, T. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor. Exp. Hematol., 20:1201–1207, 1992.
12. Persson, H., Henninghausen, L., Taub, R., DeGrado, W., and Leder, P. Antibodies to human c-myc oncogene product:evidence of an evolutionarily conserved protein induced during cell proliferation. Science (Washington DC), 225:687–693, 1984.
13. Naoe, T, Shiku, H., Kurosawa, Y., and Yamada, K. Production of monoclonal antibodies reactive with c-myc protein and analysis of the c-myc expression in leukemic cells. Acta Haematol. Jpn., 57:1481–1489, 1988.
14. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death:the significance of apoptosis. Int. Rev. Cytol., 68:251–306, 1980.
15. Cotter, T. G., Lennon, S. V., Glynn, J. M., and Green, D. R. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res., 52:997–1005, 1992.
16. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53:1945–1951, 1993.
17. Dolbeare, F., Gratzner, H., Pallavicini, M. G., and Grey, J. W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Aca. Sci. USA, 80:5573–5577, 1983.
18. Mangan, D. F., and Wahl, S. M. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J. Immunol., 147:3408–3412, 1991.
19. Tone, S., Tanaka, S., and Kato, Y. The cell cycle and cell population kinetics in the programmed cell death in the limb-buds of normal and 5-bromodeoxyuridine-treated chick embryos. Dev. Growth & Differ., 30:261–270, 1988.
20. Bertrand, R., Sarang, M., Jenkin, J., Kerrigan, D., and Pommier, Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res., 57:6280–6285, 1991.
21. Askew, D. S., Ihle, J. N., and Cleveland, J. L. Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood, 82:2079–2087, 1993.
22. Yonehara, S., Ishii, A., and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 769:1747–1756, 1989.